How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,113 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Effectiveness of Manual Treatment on Pregnancy Symptoms: Usefulness of Manual Treatment in Treating Pregnancy Symptoms Full Text available with Trip Pro

was unsuccessful underwent second round of treatment after a pause of a minimum 3 days. Patients for whom the treatment was initially successful but later relapsed also repeated whole procedure. Pregnancy symptoms analyzed in this study were heartburn, nausea, vomiting, dizziness, headache, insomnia, neck pain, hyperosmia and hypersalivating.Manual treatment successfully treated pregnancy symptoms in 91 (79.1%) patients, it was partially successful for 22 (19.1%), and unsuccessful for 2 patients (1.7%) after (...) the first treatment. After the second treatment, out of a total 56 patients, the treatment was completely successful in 40 (71.4%), partially successful in 14 (25%), and unsuccessful in 2 (3.6%) patients. The highest success rate was in eliminating headache (97.3%), vomiting (95.9%), dizziness (94.5%), nausea (92.9%), neck pain (92.9%), insomnia (91.9%), heartburn (88.8%), hyperosmia (78.5%) and hyper salivating (78%).Manual therapy in pregnancy is a drugless, etiological, usually highly effective

2018 Medical Archives

162. Polycystic ovary syndrome: metformin in women not planning pregnancy

. Metformin use is associated with gastrointestinal adverse effects (nausea, vomiting and diarrhoea), which can be severe. The Cochrane review found that metformin caused a significantly higher incidence of gastrointestinal adverse effects that were severe (leading to treatment discontinuation) compared with co-cyprindiol, and a significantly lower incidence of other severe adverse effects (weight gain, high blood pressure, depression, chest pain and headache). Among all 9 trials there was significant (...) , cardiovascular events or endometrial cancer in women with PCOS. Gastrointestinal adverse effects, which occasionally caused women to stop treatment, were more commonly reported with metformin than co-cyprindiol. Other adverse effects that caused women to stop treatment (weight gain, high blood pressure, depression, chest pain and headache) were more commonly reported with co-cyprindiol than metformin. Summary of the evidence This section gives a brief summary of the main evidence. A more thorough analysis

2013 National Institute for Health and Clinical Excellence - Advice

163. Hypertension in pregnancy

and a dipstick urine test done for proteinuria at presentation and at each antenatal visit. An explanation of the symptoms of pre-eclampsia should be given and the woman advised to seek immediate medical review if she develops any of the following (including during the first four weeks postpartum): Severe headaches (increasing frequency unrelieved by regular analgesics). Vision problems, such as blurred vision, flashing lights, double vision, or floating spots. Persistent new epigastric pain or pain (...) - Options for local implementation No QIPP indicators were found during the review of this topic. NICE quality standards NICE quality standards Women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy. Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75–150 mg of aspirin to take daily from 12 weeks until birth. Pregnant women taking antihypertensive medication

2019 NICE Clinical Knowledge Summaries

164. Antenatal care - uncomplicated pregnancy

history of pre-eclampsia. Body mass index 30 kg/m 2 or above. Pre-existing vascular disease, such as hypertension. Pre-existing renal disease. Multiple pregnancy. Symptoms of pre-eclampsia include: Severe headaches (increasing frequency and unrelieved by regular analgesics). Vision problems, such as blurred vision, flashing lights, double vision, or floating spots. Persistent new epigastric pain or pain in the right upper quadrant. Vomiting. Breathlessness. Sudden swelling of the face, hands, or feet (...) pregnancy but should avoid scuba diving and sports that may cause abdominal trauma, falls, or excessive joint stress. Working — most women can continue working during pregnancy. To allow a pregnant woman to continue working after 33 weeks, her GP or midwife must inform her employer that she may continue to do so. The law states that a women is not allowed to return to employment in the 2 weeks following childbirth. Maternity benefits — including information on entitlement to take time off work

2019 NICE Clinical Knowledge Summaries

165. The Acute Management of Thrombosis and Embolism during Pregnancy and the Puerperium

) or with other complicating factors (for example, with renal impairment or recurrent VTE). Routine platelet count monitoring should not be carried out. Obstetric patients who are postoperative and receiving unfractionated heparin should have platelet count monitoring performed every 2–3 days from days 4 to 14 or until heparin is stopped. [New 2015] How should massive life-threatening PE in pregnancy and the puerperium be managed? Collapsed, shocked women who are pregnant or in the puerperium should (...) disposal of needles and syringes. Outpatient follow-up should include clinical assessment and advice with monitoring of blood platelets and peak anti-Xa levels if appropriate (see sections 5 and 6.3). Pregnant women who develop heparin-induced thrombocytopenia or have heparin allergy and require continuing anticoagulant therapy should be managed with an alternative anticoagulant under specialist advice. Can vitamin K antagonists be used during pregnancy for the maintenance treatment of VTE? Because

2015 Royal College of Obstetricians and Gynaecologists

166. Reducing the Risk - Thrombosis and Embolism during Pregnancy and the Puerperium

with previous VTE be managed in pregnancy? (see Appendix IV) Single previous VTE Women with previous VTE should be offered prepregnancy counselling and a prospective management plan for thromboprophylaxis in pregnancy made. Those who become pregnant before receiving such counselling should be referred at the earliest opportunity in pregnancy to a clinician with expertise in thrombosis in pregnancy. C C C D D D D P PRCOG Green-top Guideline No. 37a © Royal College of Obstetricians and Gynaecologists 3 of 40 (...) be avoided antenatally and intrapartum because of the risk of anaphylactoid reaction. Oral thrombin and Xa inhibitors Non-vitamin K antagonist oral anticoagulants (NOACs) should be avoided in pregnant women. [New 2015] Use of NOACs is not currently recommended in women who are breastfeeding. [New 2015] Anti-embolism stockings The use of properly applied anti-embolism stockings (AES) of appropriate size and providing graduated compression with a calf pressure of 14–15 mmHg is recommended in pregnancy

2015 Royal College of Obstetricians and Gynaecologists

167. Chickenpox in Pregnancy

or postpartum is an option that should be considered for women who are found to be seronegative for varicella-zoster virus immunoglobulin G (VZV IgG). While universal serological antenatal testing is not recommended in the UK (see below), seronegative women identified in pregnancy could be offered postpartum immunisation. Women who are vaccinated postpartum can be reassured that it is safe to breastfeed. Can varicella be prevented in the pregnant woman at her initial antenatal visit? Women booking (...) for antenatal care should be asked about previous chickenpox/shingles infection. Women who have not had chickenpox, or are known to be seronegative for chickenpox, should be advised to avoid contact with chickenpox and shingles during pregnancy and to inform healthcare workers of a potential exposure without delay. Can varicella infection be prevented in the pregnant woman who gives a history of contact with chickenpox or shingles? When contact occurs with chickenpox or shingles, a careful history must

2015 Royal College of Obstetricians and Gynaecologists

168. Clinic and Emergency Room Evaluation and Testing of Headache. (Abstract)

Clinic and Emergency Room Evaluation and Testing of Headache. Evaluation of the headache patient in the outpatient clinic and emergency department (ED) has different focuses and goals. The focus of this paper is to review the evaluation of patients in both settings with mention of evaluation in the pediatric and pregnant patient population.  The patient's history should drive the practitioner's decision and evaluation choices. We review recommendations made by the American Board of Internal (...) Medicine and American Headache Society through the Choosing Wisely Campaign, which has an emphasis on choosing the right imaging modality for the clinical situation and elimination/prevention of medication overuse headache, as well as the US Headache Consortium guidelines for migraine headache. We will also review focusing on ED evaluation of the pediatric patient and pregnant patient presenting with headache.At the end of the review we hope to have provided you with a framework to think about

2015 Headache

169. The Influence of Manual Therapy in the Quality of Life in Tension-Type Headache

during the treatment ETTH patients may experience very occasionally photophobia or phonophobia during their episodes of headache, CTTH patients may experience very occasionally photophobia, phonophobia or mild nausea during headache episodes. Pain aggravated by movement of the head, Metabolic or musculoskeletal problems with similar headache symptoms, Previous trauma to the cervical spine, Active vertigo history Poorly controlled hypertension, Joint stiffness, atherosclerosis, or advanced (...) ClinicalTrials.gov Identifier: Other Study ID Numbers: ID004 First Posted: May 27, 2015 Last Update Posted: May 28, 2015 Last Verified: May 2015 Keywords provided by GEMMA V ESPÍ LÓPEZ, PhD, University of Valencia: Efficacy Tension-type headache Manual therapy Additional relevant MeSH terms: Layout table for MeSH terms Headache Tension-Type Headache Pain Neurologic Manifestations Signs and Symptoms Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System

2015 Clinical Trials

170. A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache

Update Posted : April 10, 2017 Sponsor: Children's Mercy Hospital Kansas City Information provided by (Responsible Party): Children's Mercy Hospital Kansas City Study Details Study Description Go to Brief Summary: The purpose of this study is to preliminarily establish the extent to which a brief aromatherapy intervention incrementally improves subjective and objective indicators of discomfort (pain, anxiety, and heart rate variability) beyond passive relaxation in youth with chronic headaches (...) . A secondary objective is to establish the safety of using aromatherapy as a treatment strategy in youth with chronic headache. The investigators hypothesize that children randomized to the aromatherapy condition will demonstrate a greater improvement in pain, anxiety, and objectively measured distress (heart rate variability) than comparable children receiving only a passive relaxation treatment (a foot bath). The investigators further hypothesize that the aromatherapy intervention will be safe and well

2015 Clinical Trials

171. Cognitive-Behavior Therapy for Posttraumatic Headache

] they are pregnant or plan to become pregnant during the trial (due to concerns about pregnancy-induced headache that may obscure findings) if a psychiatric problem is present that warrants immediate treatment based upon clinical judgment if they demonstrate significant cognitive impairment that could impact treatment adherence/benefit. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using (...) Accepts Healthy Volunteers: No Criteria Inclusion Criteria: adult (ages 18 - 70 years old) U.S. military Veterans with military service during Operations Enduring Freedom (OEF), Iraqi Freedom (OIF), and New Dawn (OND) have sustained a traumatic head injury have been diagnosed or report symptoms consistent with chronic (> 3 months) posttraumatic headache attributed to a traumatic injury sustained as part of military service. We are focusing on chronic PTHA due to the very low likelihood of headache

2015 Clinical Trials

172. Does the Addition of Manipulation Provide Added Benefit to Massage Therapy for Tension-type Headache Patients?

neck trauma Vertigo, dizziness, arterial hypertension. Joint stiffness, arteriosclerosis or advanced degenerative osteoarthritis Patients with heart devices Patients in process of pharmacological adaptation Excessive emotional tension Neurological disorders Laxity of neck soft tissues Radiological alterations General hypermobility or hyperlaxity Joint instability Pregnancy Received physical therapy treatment for headache or neck pain in the previous 3 months Suspicion of malignancy Contacts (...) %) and chronic (52.4%) TTH derived from two primary care centres, selected according to the criteria of IHS3,4, and suffering from headache for more than three months. Participants were aged between 18 and 65 years (mean ± SD: 38.9 ± 10.9 years), which included 23 men (21.9%) and 82 women (78.1%). Patients were excluded if they had suspected malignant disease, rheumatoid arthritis, pregnancy, vertigo, continuous intake of prescribed medication or those who received physical therapy in the past 3 months

2015 Clinical Trials

173. Medication Overuse Headache (MOH) and an Innovative Approach

health care system Additional relevant MeSH terms: Layout table for MeSH terms Headache Headache Disorders, Secondary Pain Neurologic Manifestations Signs and Symptoms Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases (...) Medication Overuse Headache (MOH) and an Innovative Approach Medication Overuse Headache (MOH) and an Innovative Approach - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Medication Overuse Headache (MOH

2015 Clinical Trials

174. A Study of LY2951742 in Participants With Chronic Cluster Headache

27, 2018 Last Verified: September 17, 2018 Additional relevant MeSH terms: Layout table for MeSH terms Headache Cluster Headache Pain Neurologic Manifestations Signs and Symptoms Trigeminal Autonomic Cephalalgias Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases (...) A Study of LY2951742 in Participants With Chronic Cluster Headache A Study of LY2951742 in Participants With Chronic Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study of LY2951742

2015 Clinical Trials

175. Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache

capsules to be taken when qualifying tension-type headache occurs Drug: Placebo Placebo capsule Other Name: TNX-201 Placebo Outcome Measures Go to Primary Outcome Measures : Number of Subjects Pain Free [ Time Frame: 2 hours ] Number of subjects pain free at 2 hours post-dose (Pain assessed by 4-point NRS, VAS, and binary yes/no question). 4-point NRS grades: 0=none, 1=mild, 2=moderate, 3=severe; "pain-free" defined as score = 0. VAS: 0-100 scale, anchored by verbal anchors of No Pain (0) vs. Worst (...) Imaginable Headache Pain (100). "Pain-free" was defined as a score <= 5 Secondary Outcome Measures : Number of Subjects Pain Free at 15, 30, 60, 90 Minutes and 4 Hours Post-dose (Pain Will be Assessed by 4-point NRS, VAS, and Binary Yes/no Question) [ Time Frame: 15, 30, 60, 90 minutes and 4 hours post-dose ] 4-point NRS grades: 0=none, 1=mild, 2=moderate, 3=severe. VAS: 0-100 scale, No Pain vs. Worst Imaginable Headache Pain Number of Subjects Using Rescue Medication During the 24-hour Post-dose Period

2015 Clinical Trials

176. Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache

performing a blood patch, the patient will be placed in a prone position for 1 hour. This applies to all blood patches required during her hospitalization. Procedure: Blood patch And indicated in inclusion criteria, patients in this protocol will have at least 1 blood patch. The amount of blood to be injected into the peridural space is fixed at 20 ml, but can be less in case of pain. Outcome Measures Go to Primary Outcome Measures : Headache recurrence: yes/no [ Time Frame: 24 hours after first blood (...) for pain [ Time Frame: 72 hours after blood patch ] Scale from 0.0 to 10.0. Presence/absence of complications [ Time Frame: During hospital stay (expected average of 7 days) ] Presence / absence of the following complications: nerve paresthesia; nerve damage; accidental dural puncture; subcutaneous hematoma at the puncture site; meningitis; epidural abscess; localized infection at the puncture site; encephalopathy; cerebral venous thrombosis; subdural hematoma In case of recurrence of headache

2015 Clinical Trials

177. Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department

appropriate for deep procedural sedation. Condition or disease Intervention/treatment Phase Migraine Headache Drug: Propofol Not Applicable Detailed Description: This is a prospective, open-label, observational trial to assess basic efficacy and safety in the Emergency Department treatment environment. Emergency Department patients at Einstein Medical Center Philadelphia, with migraine type headache (International Headache Classification), who continue to have severe (6/10 or greater) pain one hour after (...) (check all that apply): Unilateral Headache Pulsatile Sensation Moderate to Severe pain intensity Aggravation by physical activity or causing avoidance of physical activity (i.e. climbing stairs, walking) Headache is associated with at least one of the following symptoms (check all that apply): Nausea and/or vomiting Photophobia and/or phonophobia History of at least 5 similar headaches Within 6 hours of screening has received BOTH (via IV or PO): A Non-Steroidal Anti-Inflammatory Drug (NSAID

2015 Clinical Trials

178. The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache

headache society (IHS) criteria for migraine with or without aura of both sexes 18-70 years 45-95 kg. Exclusion Criteria: Healthy: Any type of headache (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy Intake of daily medication (except oral contraceptives). Migraine patients: Any other type of headache then migraine without aura (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy, and intake (...) terms Migraine Disorders Headache Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Sumatriptan Isosorbide Isosorbide Dinitrate Isosorbide-5-mononitrate Vasoconstrictor Agents Serotonin 5-HT1 Receptor Agonists Serotonin Receptor Agonists Serotonin Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Diuretics, Osmotic Diuretics

2015 Clinical Trials

179. The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache

meet IHS criteria for migraine with or without aura of both sexes 18-70 years 45-95 kg. Exclusion Criteria: Healthy: Any type of headache (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy Intake of daily medication (except oral contraceptives). Migraine patients: Any other type of headache then migraine without aura (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy Intake of daily (...) Last Verified: May 2017 Additional relevant MeSH terms: Layout table for MeSH terms Migraine Disorders Headache Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Cilostazol Sumatriptan Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Asthmatic Agents Respiratory System Agents Fibrinolytic Agents Fibrin Modulating Agents

2015 Clinical Trials

180. Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture Headache

Pain Score [ Time Frame: 1 day post procedure ] Numerical 0-10 (0 no pain, 10 worst pain) Headache Pain Score [ Time Frame: 3 days post procedure ] Numerical 0-10 (0 no pain, 10 worst pain) Headache Pain Score [ Time Frame: 7 days post procedure ] Numerical 0-10 (0 no pain, 10 worst pain) Secondary Outcome Measures : Functioning Score [ Time Frame: 1 day post procedure ] Functional score 0-10 (0 being able to function all tasks of daily living, 10 not able to complete activities of daily living (...) , 2016 Last Verified: September 2016 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No Keywords provided by United States Naval Medical Center, San Diego: Postdural puncture headache Epidural Blood Patch Cosyntropin PDPH Regional anesthesia Lumbar puncture ACTH Tetracosactin Additional relevant MeSH terms: Layout table for MeSH terms Headache Wounds and Injuries Post-Dural Puncture Headache Pain Neurologic Manifestations Signs and Symptoms Headache Disorders, Secondary

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>